AAAAAA

   
Results: 1-10 |
Results: 10
Inhibition of cytochrome P4502C9 activity in vitro by 5-hydroxytryptamine and adrenaline
Authors: Gervasini, G Martinez, C Agundez, JAG Garcia-Gamito, FJ Benitez, J
Citation: G. Gervasini et al., Inhibition of cytochrome P4502C9 activity in vitro by 5-hydroxytryptamine and adrenaline, PHARMACOGEN, 11(1), 2001, pp. 29-37
Association of CYP2C9 genotypes leading to high enzyme activity and colorectal cancer risk
Authors: Martinez, C Garcia-Martin, E Ladero, JM Sastre, J Garcia-Gamito, F Diaz-Rubio, M Agundez, JAG
Citation: C. Martinez et al., Association of CYP2C9 genotypes leading to high enzyme activity and colorectal cancer risk, CARCINOGENE, 22(8), 2001, pp. 1323-1326
High frequency of mutations related to impaired CYP2C9 metabolism in a Caucasian population
Authors: Garcia-Martin, E Martinez, C Ladero, JM Gamito, FJG Agundez, JAG
Citation: E. Garcia-martin et al., High frequency of mutations related to impaired CYP2C9 metabolism in a Caucasian population, EUR J CL PH, 57(1), 2001, pp. 47-49
Functionally active duplications of the CYP2D6 gene are more prevalent among larynx and lung cancer patients
Authors: Agundez, JAG Gallardo, L Ledesma, MC Lozano, L Rodriguez-Lescure, A Pontes, JC Iglesias-Moreno, MC Poch, J Ladero, JM Benitez, J
Citation: Jag. Agundez et al., Functionally active duplications of the CYP2D6 gene are more prevalent among larynx and lung cancer patients, ONCOL-BASEL, 61(1), 2001, pp. 59-63
N-acetyltransferase 2 (NAT2) genotype and colorectal carcinoma: Risk variability according to tumour site?
Authors: Agundez, JAG Lozano, L Ladero, JM Sastre, J Cerdan, FJ Diaz-Rubio, M Benitez, J
Citation: Jag. Agundez et al., N-acetyltransferase 2 (NAT2) genotype and colorectal carcinoma: Risk variability according to tumour site?, SC J GASTR, 35(10), 2000, pp. 1087-1091
Modulation of midazolam 1-hydroxylation activity in vitro by neurotransmitters and precursors
Authors: Martinez, C Gervasini, G Agundez, JAG Carrillo, JA Ramos, SI Garcia-Gamito, FJ Gallardo, L Benitez, J
Citation: C. Martinez et al., Modulation of midazolam 1-hydroxylation activity in vitro by neurotransmitters and precursors, EUR J CL PH, 56(2), 2000, pp. 145-151
Pharmacokinetic interaction of fluvoxamine and thioridazine in schizophrenic patients
Authors: Carrillo, JA Ramos, SI Herraiz, AG Llerena, A Agundez, JAG Berecz, R Duran, M Benitez, J
Citation: Ja. Carrillo et al., Pharmacokinetic interaction of fluvoxamine and thioridazine in schizophrenic patients, J CL PSYCH, 19(6), 1999, pp. 494-499
Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism
Authors: Oscarson, M McLellan, RA Gullsten, H Agundez, JAG Benitez, J Rautio, A Raunio, H Pelkonen, O Ingelman-Sundberg, M
Citation: M. Oscarson et al., Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism, FEBS LETTER, 460(2), 1999, pp. 321-327
Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H-2-receptor antagonists
Authors: Martinez, C Albet, C Agundez, JAG Herrero, E Carrillo, JA Marquez, M Benitez, J Ortiz, JA
Citation: C. Martinez et al., Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H-2-receptor antagonists, CLIN PHARM, 65(4), 1999, pp. 369-376
Slow allotypic variants of the NAT2 gene and susceptibility to early-onsetParkinson's disease
Authors: Agundez, JAG Jimenez-Jimenez, FJ Luengo, A Molina, JA Orti-Pareja, M Vazquez, A Ramos, F Duarte, J Coria, F Ladero, JM Alvarez-Cermeno, JC Benitez, J
Citation: Jag. Agundez et al., Slow allotypic variants of the NAT2 gene and susceptibility to early-onsetParkinson's disease, NEUROLOGY, 51(6), 1998, pp. 1587-1592
Risultati: 1-10 |